The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Estimated Life Expectancy in a Scottish Cohort With Type 1 Diabetes, 2008-2010
Open accessAbstract
IMPORTANCE: Type 1 diabetes has historically been associated with a significant reduction in life expectancy. Major advances in treatment of type 1 diabetes have occurred in the past 3 decades. Contemporary estimates of the effect of type 1 diabetes on life expectancy are needed. OBJECTIVE: To examine current life expectancy in people with and without type 1 diabetes in Scotland. We also examined whether any loss of life expectancy in patients with type 1 diabetes is confined to those who develop kidney disease. DESIGN, SETTING, AND PARTICIPANTS: Prospective cohort of all individuals alive in Scotland with type 1 diabetes who were aged 20 years or older from 2008 through 2010 and were in a nationwide register (n=24,691 contributing 67,712 person-years and 1043 deaths). MAIN OUTCOMES AND MEASURES: Differences in life expectancy between those with and those without type 1 diabetes and the percentage of the difference due to various causes. RESULTS: Life expectancy at an attained age of 20 years was an additional 46.2 years among men with type 1 diabetes and 57.3 years among men without it, an estimated loss in life expectancy with diabetes of 11.1 years (95% CI, 10.1-12.1). Life expectancy from age 20 years was an additional 48.1 years among women with type 1 diabetes and 61.0 years among women without it, an estimated loss with diabetes of 12.9 years (95% CI, 11.7-14.1). Even among those with type 1 diabetes with an estimated glomerular filtration rate of 90 mL/min/1.73 m2 or higher, life expectancy was reduced (49.0 years in men, 53.1 years in women) giving an estimated loss from age 20 years of 8.3 years (95% CI, 6.5-10.1) for men and 7.9 years (95% CI, 5.5-10.3) for women. Overall, the largest percentage of the estimated loss in life expectancy was related to ischemic heart disease (36% in men, 31% in women) but death from diabetic coma or ketoacidosis was associated with the largest percentage of the estimated loss occurring before age 50 years (29.4% in men, 21.7% in women). CONCLUSIONS AND RELEVANCE: Estimated life expectancy for patients with type 1 diabetes in Scotland based on data from 2008 through 2010 indicated an estimated loss of life expectancy at age 20 years of approximately 11 years for men and 13 years for women compared with the general population without type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cardiovascular disease remains the major cause of premature morbidity and mortality, with data119,120 suggesting an 8–13-year shorter life expectancy for people with type 1 diabetes than for healthy individuals.”
From Type 1 diabetes (2018) · cites this paper as [120]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Due in part to the success of modern diabetes management, people with type 1 diabetes are living longer, and the population of these people over 65 years of age is growing (121-123).”
From 13. Older Adults: Standards of Care in Diabetes—2024 (2024) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Due in part to the success of modern diabetes management, people with type 1 diabetes are living longer, and the population of these people over 65 years of age is growing (136-138).”
From 13. Older Adults: Standards of Care in Diabetes—2025 (2025) · cites this paper as [136]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In Scotland, mortality rates in 2008–2010 increased from 31.9 and 24.2 per 1,000 person-years in men and women, respectively, with T1DM who were aged 60–64 years to 142.7 in men and 171.3 in women aged ≥80 years39.”
From The epidemiology of type 1 diabetes mellitus in older adults (2025) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In Scotland, reductions in life expectancy for people with T1DM aged 60–64 years were 5.6 years and 7.1 years for men and women, respectively39.”
From The epidemiology of type 1 diabetes mellitus in older adults (2025) · cites this paper as [39]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Due in part to the success of modern diabetes management, people with type 1 diabetes are living longer, and the population of people over 65 years with type 1 diabetes is growing (154–156).”
From 13. Older Adults: Standards of Care in Diabetes—2026 (2026) · cites this paper as [154]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2000) · doi:10.32614/r.manuals · Cited by 355,893
Patterson, C. C., Dahlquist, G. G., Gyürüs, E., Green, A., & Soltész, G. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60568-7 · Cited by 1,854
Introduction to Stochastic Processes in Biostatistics
Bartlett, M. S., & Chiang, C. L. (1969) · Revue de l Institut International de Statistique / Review of the International Statistical Institute · doi:10.2307/1402301 · Cited by 684
The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes
Groop, P.-H., Thomas, M. C., Moran, J. L., Wadèn, J., Thorn, L. M., Mäkinen, V.-P., Rosengård-Bärlund, M., Saraheimo, M., Hietala, K., Heikkilä, O., et al. (2009) · Diabetes · doi:10.2337/db08-1543 · Cited by 638
Measuring and explaining the change in life expectancies
Arriaga, E. E. (1984) · Demography · doi:10.2307/2061029 · Cited by 630
Type 1 Diabetes Mellitus and Cardiovascular Disease
de Ferranti, S. D., de Boer, I. H., Fonseca, V. A., Fox, C. S., Golden, S. H., Lavie, C. J., Magge, S. N., Marx, N., McGuire, D. K., Orchard, T. J., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000034 · Cited by 516
de Ferranti, S. D., de Boer, I. H., Fonseca, V. A., Fox, C. S., Golden, S. H., Lavie, C. J., Magge, S. N., Marx, N., McGuire, D. K., Orchard, T. J., et al. (2014) · Diabetes Care · doi:10.2337/dc14-1720 · Cited by 444
High Risk of Cardiovascular Disease in Patients With Type 1 Diabetes in the U.K.
Soedamah‐Muthu, S. S., Fuller, J., Mulnier, H. E., Raleigh, V. S., Lawrenson, R. A., & Colhoun, H. M. (2006) · Diabetes Care · doi:10.2337/diacare.29.04.06.dc05-1433 · Cited by 395
Self-citationLivingstone, S. J., Looker, H. C., Hothersall, E. J., Wild, S. H., Lindsay, R. S., Chalmers, J., Cleland, S. J., Leese, G., McKnight, J. A., Morris, A. D., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001321 · Cited by 356
Self-citationOrchard, T. J., Secrest, A. M., Miller, R. G., & Costacou, T. (2010) · Diabetologia · doi:10.1007/s00125-010-1860-3 · Cited by 317
Cited by
Sorted by citations
Items 501–600 of 622
Freitas, S. C. F., Dutra, M. R. H., Dourado, P. M. M., de Miranda, V. H. M., dos Santos, C. P., Sanches, Í. C., Irigoyen, M. C., & Angelis, K. D. (2024) · Pharmaceuticals · doi:10.3390/ph17050577 · Cited by 1
Dawnbringer, J., Hill, H., Lundgren, M., Catrina, S., Caballero-Corbalán, J., Cederblad, L., Carlsson, P., & Espes, D. (2024) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2024-004350 · Cited by 1
Markowitz, B., Pritlove, C., Mukerji, G., Lavery, J. V., Parsons, J. A., & Advani, A. (2018) · Diabetes · doi:10.2337/db18-842-p · Cited by 1
Deola, S., Guerrouahen, B. S., Sidahmed, H., Al-Mohannadi, A., Elnaggar, M., Elsadig, R., Abdelalim, E. M., Petrovski, G., Gadina, M., Thrasher, A. J., et al. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1652-y · Cited by 1
Rawshani, A., Rawshani, A., Sattar, N. A., Franzen, S., McGuire, D. K., Eliasson, B., Svensson, A., Zethelius, B., Miftaraj, M., Rosengren, A., et al. (2019) · Yearbook of pediatric endocrinology · doi:10.1530/ey.16.10.17 · Cited by 1
Self-citationRisque cardiovasculaire du patient diabétique de type 1
Vergès, B. L. (2021) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2021.03.004 · Cited by 1
Identifying and Reducing Disparities in Young Adults With Diabetes
FINNAN, M., & Agarwal, S. (2021) · Diabetes Spectrum · doi:10.2337/dsi21-0010 · Cited by 1
Lablanche, S., Camille, L., & Benhamou, P. (2019) · Springer eBooks · doi:10.1007/978-3-319-98119-2_7 · Cited by 1
Espes, D. (2016) · Uppsala University Publications (Uppsala University) · Cited by 1
McGurnaghan, S. J., Weir, A., Bishop, J., Kennedy, S., Blackbourn, L. A. K., Hutchinson, S. J., Caparrotta, T. M., Mellor, J., Jeyam, A., O’Reilly, J. E., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3640560 · Cited by 1
Self-citationMacrovascular Disease in Type 1 Diabetes
Petrie, J. R. (2022) · doi:10.1093/med/9780198870197.003.0281 · Cited by 1
Self-citationAmbler, G. R., Cameron, F. J., Joshi, K., & Wherrett, D. K. (2019) · Wiley eBooks · doi:10.1002/9781119152712.ch15 · Cited by 1
New Contributions Towards Meal and Exercise Announcement-Free Artificial Pancreas Systems
Sala-Mira, I. (2023) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/192684 · Cited by 1
Automated Insulin Delivery for People With Type 1 Diabetes and High HbA1c: Is It Time?
Wheeler, B. J., & Boucsein, A. (2024) · Diabetes Care · doi:10.2337/dci24-0076 · Cited by 1
Insulin post-transcriptional regulation via PARP12-mediated ADP- ribosylationPreprint
Sarkar, S., Li, F., You, Y., Elliott, E. C., Zemaitis, K. J., Kim, H., Markillie, L. M., Traeger, J. C., Powell, S. M., Ramos-Rodríguez, M., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6473437/v1 · Cited by 1
E-health: wat wordt/is de toekomst bij de behandeling van diabetes?
Veeze, H., & Aanstoot, H. (2015) · Tijdschrift voor kindergeneeskunde · doi:10.1007/s12456-015-0010-8
Type 1 diabetes cuts lifespan by more than a decade
Greener, M. (2015) · Independent Nurse · doi:10.12968/indn.2015.2.15
Diabetes today: missed opportunities, unacceptable variations in care and ‘indescribable tragedy’
Greener, M. (2015) · Practical Diabetes · doi:10.1002/pdi.1927
Thomas, J. (2015) · Journal of Bioresource Management
Picard, S., & Vasilevski, D. (2016) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(16)30119-5
Recommendations of the new NICE guidance on type 1 diabetes
Poole, R. (2015) · Prescriber · doi:10.1002/psb.1418
Wiederholte Ketoazidosen bei jungen Risiko-Typ-1-Diabetikern oft tödlich
Fritschka, E. (2016) · Info Diabetologie · doi:10.1007/s15034-016-0943-8
Gestational Diabetes: A Conundrum for Mother, Baby and Physician
Bofill, J. A. (2015) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000567
Nazarko, L. (2017) · Practice Nursing · doi:10.12968/pnur.2017.28.6.242
Kidney Transplantation in the Diabetic Patient
Gruessner, A. C., & Gruessner, R. W. G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801734-0.00045-x
Erhöhte Mortalität bei Typ-1-Diabetes-Patienten auch ohne Albuminurie
Fries, C. (2018) · Der Diabetologe · doi:10.1007/s11428-018-0343-x
Does Diagnosis of Diabetes Affect Consumers’ Attitudes towards Pro-Health Food?
Waszkowiak, K., Mikołajczyk, H., Jędrusek‐Golińska, A., Szymandera-Buszka, K. E., & Kobus‐Cisowska, J. (2018) · Handel Wewnętrzny
Petrie, J. R., & Salt, I. P. (2019) · Springer eBooks · doi:10.1007/978-3-030-16481-2_40
Self-citationNarita, K., Hoshide, S., & Kario, K. (2019) · American Journal of Hypertension · doi:10.1093/ajh/hpz131
Conte, C., & Secchi, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814833-4.00023-x
IBRAHIM, M. D. A. I. A. E. M., & Abulmeaty, M. M. A. (2018) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2018.60311
A kardiovaszkuláris kockázat csökkentése 1-es típusú diabetes mellitusban, felnőttkorban
Hosszúfalusi, N., & Kempler, M. (2019) · Diabetologia Hungarica · doi:10.24121/dh.2019.12
Methods in Childhood Health: Chronic Disease Epidemiology and Age Estimation
Gesuita, R., Ferrante, L., Skrami, E., & Carle, F. (2020) · Springer eBooks · doi:10.1007/978-3-030-33832-9_26
LA MALATTIA RENALE CRONICA NON-ALBUMINURICA NEL DIABETE MELLITO TIPO 1
Garofolo, M., Daniele, G., & Penno, G. (2019) · il Diabete · doi:10.30682/ildia1904a
Use of routinely collected data to assess outcomes in people with diabetes
Holman, N. (2020) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.78967
Setting Limits on Neural Network’s Predictive Capacity in T1D Blood Glucose ConcentrationPreprint
Chuna, T. (2020) · medRxiv · doi:10.1101/2020.08.04.20117812
Self – Management Strategies as a Pillar in Treatment for Patients With Diabetes Mellitus
Builes, F., & Fernanda, L. (2020) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Ray, S. L., Coulson, D. J., Yeoh, M. L. Y., Bakhashab, S., Tamara, A., Latief, J. S., & Weaver, J. U. (2020) · doi:10.21203/rs.3.rs-31267/v1
FFI Reports 油溶性酸化防止剤製剤 サンメリンYO-1844
岡浩司, & 田中久志 (2013) · 食品・食品添加物研究誌
Centenarian Rate, Life Expectancy, and Autoimmune Diseases
Lens-Pechakova, L. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_470
Kuo, R. Y. L., Ng, M., Prieto‐Alhambra, D., & Furniss, D. (2021) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000007826
Presentation and Natural History of Type 1 Diabetes
Brooks, A. M. (2022) · doi:10.1093/med/9780198870197.003.0244
Therapeutic potential of zein-based nanoparticles
Reboredo, C. (2022) · doi:10.15581/10171/62894
von Herrath, M., & Coppieters, K. T. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735949131.793562193
Aronow, W. S. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727521391.793538499
Centenarian Rate, Life Expectancy, and Autoimmune Diseases
Lens-Pechakova, L. S. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_470-1
JENDLE, J. H., Ampudia‐Blasco, F. J., Füchtenbusch, M., & Pozzilli, P. (2021) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2021.1.1.12
Xu, L., Wang, W., Liang, S., Wang, D., & Song, W. (2020) · Research Square · doi:10.21203/rs.3.rs-91100/v1
Akutkomplikationen des Diabetes mellitus – Schulungsinhalte richtig vermitteln
Ehrmann, D. (2022) · Diabetologie und Stoffwechsel · doi:10.1055/a-1723-5181
Duin, S., Lode, A., Ludwig, B., & Gelinsky, M. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839165498-00233
Patil, V. P., & Sollinger, H. W. (2022) · Oxford University Press eBooks · doi:10.1093/med/9780192858443.003.0014
Suppawittaya, K. (2022) · The Proceedings of the International Conference on Research in Education, Teaching and Learning. · doi:10.33422/5th.icetl.2022.06.150
Verduzco-Aguirre, H. C., Penados-Ovalle, M. E., & Mancillas‐Adame, L. G. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2022.6828
Blood Pressure Disorders in Diabetic Children and Adolescents
Lurbe, E. (2023) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-031-13009-0_2
Maternal and Childhood Diet and Human Type 1 Diabetes Risk
Abela, A. G., & Fava, S. (2022) · Journal of Endocrinology and Metabolism · doi:10.14740/jem846
Accelerating data-driven discover in type 1 diabetes: an informatics-based approach
Tallon, E. M. (2022) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/94294
Typ-1-Diabetes: Screening, Prävention und neue Therapien
Kick, K., Teichgräber, F. J., & Achenbach, P. (2023) · Diabetes aktuell · doi:10.1055/a-2093-9851
The Story of Diabetes and its Causes
Malboosbaf, R., & Hatami, N. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815196535123010004
Pitoglou, S., Αναστασίου, Α., & Koutsouris, D. (2024) · Preprints.org · doi:10.20944/preprints202401.1855.v1
Update on the etiopathogenesis of type 1 diabetes mellitus in children
Stana, B. A. (2023) · Pediatru ro · doi:10.26416/pedi.72.4.2023.9275
Kwok, C. S., Qureshi, A. I., Phillips, A., Lip, G. Y. H., Hanif, W., & Borovac, J. A. (2024) · Diagnostics · doi:10.3390/diagnostics14151607
Vikulova, O. K., Zheleznyakova, A. V., Kutakova, D. V., Startseva, M. A. S., Исаков, М. А., Серков, А. А., Pershina-Miliutina, A. P., Trubitsyna, N. P., Мацюк, Е. М., Смирнова, Н. Б., et al. (2024) · Consilium Medicum · doi:10.26442/20751753.2024.12.203085
Winkley, K., & Forbes, A. (2025) · Wiley eBooks · doi:10.1002/9781394205066.ch7
Insulin Resistance in Type 1 Diabetes and Its Treatment Strategies
孙, 全. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.153617
Ketogenic Metabolic Therapy as a Treatment for Mental Health Disorders
(2025) · Frontiers research topics · doi:10.3389/978-2-8325-6338-0
Spring Meeting of the Young Researchers of SID, SIGG, SIIA, SIMI, SIPREC, SISA
D’Ardes, D., Bianconi, V., Dalt, L. D., D’Onofrio, L., Macchi, C., Visco, V., Cappelluti, M. A., Parrotta, I., Greco, C., Bencivenga, L., et al. (2025) · European Atherosclerosis Journal · doi:10.56095/eaj.v4i1.89
Épidémiologie du diabète et de la rétinopathie diabétique
Massin, P., Dupas, B., Erginay, A., Feldman, S., & Lecleire-Collet, A. (2025) · Elsevier eBooks · doi:10.1016/b978-2-294-78350-0.00001-5
Persistent urinary metabolic signatures in children with type 1 diabetes
Nakayasu, E. S., Flores, J. E., Bramer, L., Chin, J., Kim, Y., Syed, F., Zink, E., Frohnert, B. I., Evans‐Molina, C., Kaplowitz, P. B., et al. (2025) · Next research. · doi:10.1016/j.nexres.2025.100725
Lipták, L., Lipták, K., Hermann, P., Rózsa, N. K., Végh, D., Menyhárt, A., Kempler, P., Balaton, G., & Bányai, D. (2025) · Diabetologia Hungarica · doi:10.24121/dh.2025.24
Factors Involved in the Progression of Preclinical Atherosclerosis in People with Type 1 Diabetes
Viñals, C., Conget, I., Granados, M., Solà, C., Ayala, D., Mesa, A., Serés‐Noriega, T., Doménech, M., Perea, V., Blanco, J., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14176004 · Cited by 1
Associations between daily dietary carbohydrate intake and TIR in adults with type 1 diabetes
Cai, Y., Li, X., Xiong, X., Zhang, L., He, J., & Su, H. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1638849 · Cited by 1
Lipid metabolism in type 1 diabetes initiation and progression to vascular disease
Borowsky, N. S., Michel, R., Hirani, K., & Vendrame, F. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-19116-9.00028-2
Fériz, K., Corral, P., Iriarte-Durán, M. B., Giraldo, C. M. G., Nardelli, N., Arias‐Valderrama, O., & Gómez-Ayala, M. C. (2025) · Current Diabetes Reports · doi:10.1007/s11892-025-01613-2
Batth, J., Langworthy, B., Kumar, A. D., Alvear, A. B., Chow, L. S., & Kohlenberg, J. D. (2025) · AACE Endocrinology and Diabetes · doi:10.1016/j.aed.2025.11.006
Algeffari, M., & Alotaibi, E. A. (2025) · Cureus · doi:10.7759/cureus.98093
Camoin, M., Velho, G., Saulnier, P.-J., Potier, L., Abouleka, Y., Carpentier, C., Dubois, S. G., Larroumet, A., Rigalleau, V., Gand, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19736409
Giménez‐Pérez, G., Viñals, C., Mata-Cases, M., Vlacho, B., Real, J., Franch‐Nadal, J., Ortega, E., & Mauricio, D. (2024) · Figshare · doi:10.6084/m9.figshare.26604307
Camoin, M., Velho, G., Saulnier, P.-J., Potier, L., Abouleka, Y., Carpentier, C., Dubois, S. G., Larroumet, A., Rigalleau, V., Gand, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19736406
Camoin, M., Velho, G., Saulnier, P.-J., Potier, L., Abouleka, Y., Carpentier, C., Dubois, S. G., Larroumet, A., Rigalleau, V., Gand, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19736400
Mantovani, A., Morieri, M. L., Palmisano, L., Masulli, M., Cossu, E., Baroni, M. G., Bonomo, K., Cimini, F. A., Cavallo, G., Phd, R. B., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26609649
Camoin, M., Velho, G., Saulnier, P.-J., Potier, L., Abouleka, Y., Carpentier, C., Dubois, S. G., Larroumet, A., Rigalleau, V., Gand, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19736403
Sudomotor dysfunction reflects early atherosclerosis risk in adults with type 1 diabetes
Naskręt, D., Gandecka, A., Kulecki, M., Araszkiewicz, A., & Zozulińska‐Ziółkiewicz, D. (2026) · Scientific Reports · doi:10.1038/s41598-026-36292-w
Mallik, R., Marples, O., Vijayaraghavan, S., Garrett, C. J., Chowdhury, T. A., Anderson, J., & Huda, M. S. (2026) · Primary care diabetes · doi:10.1016/j.pcd.2026.02.006
Multi-omics data compendium of pancreatic islet and β cell responses to pro-inflammatory cytokinesPreprint
Sarkar, S., Flores, J. E., Nune, N., Ramos-Rodríguez, M., Yi, X., Roca-Rivada, A., Maestas, M. M., Gluth, A., Syed, F., Kim, Y., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-8779056/v1
Mo, Y., Hernandez, R., Schneider, S., GONZALEZ, J. S., Hoogendoorn, C. J., Tapia, V. A., & Pyatak, E. A. (2026) · Journal of Behavioral Medicine · doi:10.1007/s10865-026-00643-9
Type 1 Diabetes: Pathophysiology and Treatment Considerations for Cardiovascular Risk and Disease
Tommerdahl, K. L., & Bjornstad, P. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-87862-3.00005-7
Idoate-Bayón, A., Ainzúa, E., & Marqués, J. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02869-5 · Cited by 1
Cheng, Y., Yan, P., Yue, H., Han, C., & Wang, B. (2026) · Scientific Reports · doi:10.1038/s41598-026-45999-9
Les cellules MAIT dans le diabète de type 1 chez l'homme
Nel, I. (2019) · theses.fr (ABES) · doi:10.70675/8eaa5bd8z1217z4729z8c2ezb385e0dbc1a9
Gutierrez, S. F. (2020) · theses.fr (ABES) · doi:10.70675/67bbdcd2z3827z4bcbz87efzb280ed04bc58
Oxydation de l’ADN, longueur des télomères, et complications vasculaires du diabète de type 1
Sanchez, M. (2019) · theses.fr (ABES) · doi:10.70675/aeabd02dz7749z4827zb74fz27dea8ab892e
Role of extracellular vesicles in type 1 diabetes
Giri, K. R. (2020) · theses.fr (ABES) · doi:10.70675/0b17ca8bz26a4z454bz9cd6zfce0f6d3ddaf
Role of MAIT cells in virally-induced type 1 diabetes by Coxsackievirus B4
Rouland, M. (2022) · theses.fr (ABES) · doi:10.70675/71d8ae9cz623cz4299zaa75zde7eff17dcf2
Metadata
- Authors
- Livingstone, S. J., Levin, D., Looker, H. C., Lindsay, R. S., Wild, S. H., Joss, N., Leese, G., Leslie, P., McCrimmon, R. J., Metcalfe, W., McKnight, J. A., Morris, A. D., Pearson, D. W. M., Petrie, J. R., Philip, S., Sattar, N. A., Traynor, J. P., & Colhoun, H. M.
- Affiliations
- University of Dundee (GB)
- University of Glasgow (GB)
- University of Edinburgh (GB)
- Raigmore Hospital (GB)
- Borders General Hospital (GB)
- Scottish Renal Registry, Paisley, Scotland
- Western General Hospital (GB)
- NHS Grampian (GB)
- ORCID
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2015-01-06
- Volume
- 313
- Issue
- 1
- Pages
- 37
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC4426486
- OpenAlex
- W1965748339
- Cited by
- 621
- References
- 19
- Citations by year
- 2026: 39 · 2025: 46 · 2024: 49 · 2023: 55 · 2022: 66 · 2021: 64 · 2020: 59 · 2019: 62 · 2018: 51 · 2017: 39 · 2016: 48 · 2015: 42
- FWCI
- 52.16
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Funders
- Wellcome Trust (086113)
- Diabetes UK (10/0004010)
- Medical Research Council (MR/M501633/1, MR/K007017/1)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- type 1 diabetes, life expectancy, life expectancy loss, kidney disease, estimated glomerular filtration rate, ischemic heart disease, diabetic ketoacidosis, diabetic coma, sex differences, causes of death, Scotland, life expectancy at age 65
- MeSH terms
- Adult, Aged, Aged, 80 and over, Cause of Death, Diabetes Mellitus, Type 1, Diabetic Coma, Female, Humans, Life Expectancy, Male, Middle Aged, Prospective Studies, Scotland, Sex Factors, Myocardial Ischemia, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
